Do you suffer from painful kidney stones?
Urocit®-K 15 mEq (Potassium Citrate) Extended-release tablets
may be right for you.
If you have experienced a kidney stone, you know how painful it can be. Urocit-K, available in 3 dosage strengths, is a prescription treatment that restores the chemical balance in the kidneys which helps prevent kidney stones. It reduces the formation of several common types of kidney stones, including calcium oxalate and uric acid stones. The highest strength, Urocit-K 15 mEq, is designed to minimize the number of tablets you may need to take each day.
Effectively treated a variety of stone conditions1
Kept new stones from forming in more than 90% of patients2,3,4
Understanding and preventing kidney stones
It’s estimated that if a person gets a stone, there is a 30% to 50% chance of getting
another stone within 5 years.5 The good news is that most kidney stones can be
managed with a combination of medication, diet, and lifestyle changes.
kidney stones develop, how they are treated, and what you can do to avoid getting them in the future.
information about kidney stones for you to use to
help reduce your chances of developing another
You can download a copy of
this patient brochure, which
provides dietary guidance by
medical experts, via the link
Available in English and
about how stones are formed, various types of
stones, common places in your body where stones
form, and why stones may come back.
information about kidney stones and how to prevent
them, as well as useful tools and resources to guide
pills you have to take every day.1
References: 1. Urocit-K [package insert]. San Antonio, TX: Mission Pharmacal Company. 2. Pak CYC, Fuller C, Sakhaee K, et al. Long-term treatment of calcium nephrolithiasis with potassium citrate. J Urol. 1985;134(1):11-19. 3. Preminger GM, Sakhaee K, Skurla C, et al. Prevention of recurrent calcium stone formation with potassium citrate therapy in patients with distal renal tubular acidosis. J Urol. 1985;134(1):20-23. 4. Pak CYC, Peterson R, Sakhaee K, et al. Correction of hypocitraturia and prevention of stone formation by combined thiazide and potassium citrate therapy in thiazide-unresponsive hypercalciuric nephrolithiasis. Am J Med. 1985;79(3):284-288. 5. Lipkin ME, Preminger GM. Demystifying the medical management of nephrolithiasis. Rev Urol. 2011;13(1):34-38.
INDICATIONS: Urocit®-K (potassium citrate) extended-release tablets are a prescription medicine used in the management of two common types of kidney stones: calcium oxalate stones and uric acid stones. Urocit-K can also help treat certain metabolic problems (acidosis) caused by kidney disease.
Important Safety Information
Urocit-K is not for everyone. You should not take Urocit-K if you:
- Have high levels of potassium in your blood, or you have any condition that may put you at risk for high blood potassium such as chronic kidney failure, uncontrolled diabetes, severe dehydration (loss of body water), strenuous exercise if you are not used to it, adrenal insufficiency (your adrenal glands do not produce enough of certain chemicals), or you have a condition that causes extensive breakdown of tissues in your body, such as severe burns
- Are taking medicines that can increase potassium levels such as triamterene, spironolactone, or amiloride
- Have trouble swallowing tablets, or have certain conditions that do not allow the tablets to pass through your body, such as delayed emptying of the stomach, or narrowing or blockage of your esophagus or intestines
- Are taking medications known as anticholinergics, which are used to treat stomach cramps, diarrhea, dizziness or motion sickness, or certain urinary disorders
- Have stomach or intestinal ulcers, a urinary tract infection, or kidney disease
Tell your doctor about your medical history, including if you have the following conditions:
- Kidney disease
- Heart problems, such as a heart attack or heart failure
- Are pregnant or plan to become pregnant, or are breastfeeding or plan to breastfeed
It is important to tell your doctor about all your medical conditions and all medicines that you take. This may reduce the risk of serious side effects. Certain medicines can interact with Urocit-K and irritate your stomach and intestines. If you experience severe vomiting, abdominal pain, black, tarry stools, or other signs of intestinal bleeding, stop taking Urocit-K and see your doctor immediately. Other drugs or medical conditions can increase the levels of potassium in your blood, which can lead to cardiac arrest or death. These serious and potentially fatal reactions can occur rapidly with no noticeable symptoms.
The most common side effects of Urocit-K are abdominal discomfort, vomiting, diarrhea, loose stools, or nausea. Taking each dose with meals or snacks can help reduce these side effects, or you can talk to your doctor about reducing your dose.
These are not all the possible side effects of Urocit-K. Call your doctor for medical advice about side effects. You may report negative side effects to Mission Pharmacal Company at 1-800-298-1087, or to the FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.